Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Taro: Fiscal Q4 Earnings Snapshot

Taro: Fiscal Q4 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q3 Earnings Snapshot

Taro: Fiscal Q3 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q2 Earnings Snapshot

Taro: Fiscal Q2 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q1 Earnings Snapshot

Taro: Fiscal Q1 Earnings Snapshot

TARO : 42.97 (unch)
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro

/PRNewswire/ -- As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun...

TARO : 42.97 (unch)
Why Shares of Taro Pharmaceutical Are Rising Tuesday

The company is mulling a buyout offer from Sun Pharmaceutical.

TARO : 42.97 (unch)
Taro: Fiscal Q4 Earnings Snapshot

Taro: Fiscal Q4 Earnings Snapshot

TARO : 42.97 (unch)
Taro Provides Results for December 31, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022.

TARO : 42.97 (unch)
Taro to Release Third Quarter Results on January 24, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January...

TARO : 42.97 (unch)
Taro: Fiscal Q2 Earnings Snapshot

Taro: Fiscal Q2 Earnings Snapshot

TARO : 42.97 (unch)

Barchart Exclusives

Stocks Soar Before the Open as Fed’s Big Rate Cut Boosts Sentiment, U.S. Economic Data and FedEx Earnings on Tap
September S&P 500 E-Mini futures (ESU24) are up +1.48%, and September Nasdaq 100 E-Mini futures (NQU24) are up +2.03% this morning on expectations the Federal Reserve’s half-percentage-point rate cut will steer the U.S. economy toward a “soft landing,” while investors awaited a new round of U.S. economic data and an earnings report from delivery services giant FedEx. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar